We are pleased to present our 2022 Year in Review, showcasing the important progress we’ve made in the fight against Alzheimer’s disease over the last year right here in Massachusetts and New Hampshire. Our staff, community partners, volunteers, and public policy advocates have worked tirelessly to support the 156,000 individuals living with this disease across our two states.
We are pleased to present our 2022 Year in Review, showcasing the important progress we’ve made in the fight against Alzheimer’s disease and all other dementia. Our staff, board members, community partners, volunteers, and public policy advocates have worked tirelessly to support the 156,000 individuals living with this disease across our two states.
As life continued to return to a new normal this year, we are pleased to have provided uninterrupted care and support services for our constituents. Most of our staff have adopted a hybrid work schedule, and we reopened offices in Bedford, NH and Worcester, MA earlier this year. Our Waltham, MA office has remained open.
We continue to increase the number of in-person education programs, support groups, and early-stage engagement programs we offer, while maintaining a robust virtual calendar. Over the past year, over 30,000 people accessed the full range of our programs and services, delivered at no cost to families.
This year, our generous supporters helped us raise more than $15 million to continue funding research and care and support programs in local communities across our two states. Our advocacy efforts resulted in increased federal resources for research and caregiver support.
We continue to expand our diversity and inclusion efforts, reaching into new communities and strengthening our volunteer base, while expanding our awareness activities into underserved communities to reach high-risk populations. We are forging new partnerships with community leaders and grassroots organizations, having connected with more than 36 new partners over the last year.
We have over $20 million in active funding awarded to local researchers through our International Research Grants Program, ensuring that we will continue to have an impact on the quest for an effective treatment for this devastating disease.
All of this wouldn’t be possible without you, and we are tremendously grateful for your continued support.
Jean Morse Jones, Chair, Board of Directors
James Wessler, CEO, MA/NH Chapter and New England Regional Leader